KCM
MDT icon

Kennedy Capital Management’s Medtronic MDT Stock Holding History

Kennedy Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.13M Sell
24,544
-1,074
-4% -$103K 0.05% 413
2025
Q4 		$2.46M Sell
25,618
-172
-0.7% -$16.7K 0.05% 400
2025
Q3 		$2.46M Buy
+25,790
New +$2.37M 0.05% 417

Other funds holding MDT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Kennedy Capital Management's MDT Position: Q1 2026 in Review

Kennedy Capital Management reduced its Medtronic (MDT) stake by 4.2% in Q1 2026, selling an estimated $103K and leaving 24,544 shares worth $2.13M. The position accounts for 0.05% of the portfolio, ranked #413.

Kennedy Capital Management first reported a position in MDT in Q3 2025 and has held it in 3 quarters since. The position peaked at $2.46M in Q4 2025. 2,229 funds tracked by Wall St. Rank hold MDT as of Q1 2026.

  • Kennedy Capital Management held 24,544 shares of Medtronic worth $2.13M as of Q1 2026.
  • Kennedy Capital Management sold 1,074 Medtronic shares in Q1 2026, an estimated $103K.
  • Medtronic made up 0.05% of Kennedy Capital Management's portfolio in Q1 2026, its #413 holding.
  • Kennedy Capital Management first reported a position in Medtronic in Q3 2025 and has held it in 3 quarters since.
  • Kennedy Capital Management's Medtronic position peaked at $2.46M in Q4 2025.
  • 2,229 funds tracked by Wall St. Rank held Medtronic as of Q1 2026.

Based on Kennedy Capital Management's 13F filing for Q1 2026, filed 13 May 2026.